ACAD
34.83
+0.38
+1.10%
AEMD
3.35
-0.4
-10.67%
APRI
2.25
-0.04
-1.75%
ARNA
1.46
+0.01
+0.69%
ATEC
2.19
+0.12
+5.80%
CNAT
4.82
+0.23
+5.01%
CRXM
0.2
0.00
0.00%
CYTX
1.65
+0.01
+0.61%
DXCM
82.62
+6.54
+8.60%
GNMK
13.4
+0.26
+1.98%
HALO
13.53
+0.07
+0.52%
ILMN
170.58
+2.89
+1.72%
INNV
0.11
0.00
+4.08%
INO
6.05
+0.1
+1.68%
ISCO
1.78
+0.13
+7.88%
ISIS
57.56
0.00
0.00%
LGND
104.78
+0.99
+0.95%
LPTN
2.93
-0.08
-2.66%
MBVX
2.27
-0.24
-9.56%
MEIP
1.54
-0.03
-1.91%
MNOV
5.87
+0.06
+1.03%
MRTX
5.15
+0.05
+0.98%
MSTX
0.114
+0.007
+6.542%
NBIX
41.98
+0.48
+1.16%
NUVA
74.85
+0.56
+0.75%
ONCS
1.27
+0.02
+1.60%
ONVO
3.03
+0.02
+0.66%
OREX
3.98
-0.02
-0.50%
OTIC
12.85
-0.25
-1.91%
QDEL
21.84
+0.17
+0.76%
RCPT
231.96
0.00
0.00%
RGLS
1.4
+0.15
+12.00%
RMD
71.57
+0.26
+0.36%
SPHS
2.87
+0.29
+11.24%
SRNE
4.1
-0.1
-2.38%
TROV
1
-0.15
-13.04%
VICL
2.15
+0.02
+0.94%
VOLC
18
0.00
0.00%
ZGNX
10.45
+0.05
+0.48%
ACAD
34.83
+0.38
+1.10%
AEMD
3.35
-0.4
-10.67%
APRI
2.25
-0.04
-1.75%
ARNA
1.46
+0.01
+0.69%
ATEC
2.19
+0.12
+5.80%
CNAT
4.82
+0.23
+5.01%
CRXM
0.2
0.00
0.00%
CYTX
1.65
+0.01
+0.61%
DXCM
82.62
+6.54
+8.60%
GNMK
13.4
+0.26
+1.98%
HALO
13.53
+0.07
+0.52%
ILMN
170.58
+2.89
+1.72%
INNV
0.11
0.00
+4.08%
INO
6.05
+0.1
+1.68%
ISCO
1.78
+0.13
+7.88%
ISIS
57.56
0.00
0.00%
LGND
104.78
+0.99
+0.95%
LPTN
2.93
-0.08
-2.66%
MBVX
2.27
-0.24
-9.56%
MEIP
1.54
-0.03
-1.91%
MNOV
5.87
+0.06
+1.03%
MRTX
5.15
+0.05
+0.98%
MSTX
0.114
+0.007
+6.542%
NBIX
41.98
+0.48
+1.16%
NUVA
74.85
+0.56
+0.75%
ONCS
1.27
+0.02
+1.60%
ONVO
3.03
+0.02
+0.66%
OREX
3.98
-0.02
-0.50%
OTIC
12.85
-0.25
-1.91%
QDEL
21.84
+0.17
+0.76%
RCPT
231.96
0.00
0.00%
RGLS
1.4
+0.15
+12.00%
RMD
71.57
+0.26
+0.36%
SPHS
2.87
+0.29
+11.24%
SRNE
4.1
-0.1
-2.38%
TROV
1
-0.15
-13.04%
VICL
2.15
+0.02
+0.94%
VOLC
18
0.00
0.00%
ZGNX
10.45
+0.05
+0.48%
Home » Archive by Category

Xconomy

14 For ’17: Key Clinical Data to Watch For Next Year (Part 1)

December 21, 2016 – 12:10 pm

[Updated, 4:28 pm ET, see below] After years of research, frustration, hype, and millions (sometimes hundreds of millions) of dollars invested, a drug program boils down to the clinical…

[[Click headline to continue reading.]]

Acadia Drug Shows Early Promise in Treating Alzheimer’s Psychosis

December 20, 2016 – 10:22 am

An Acadia Pharmaceuticals drug developed to treat hallucinations and delusions experienced by Parkinson’s disease patients is now showing signs it could also treat similar psychoses associated with…

[[Click headline to continue reading.]]

Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More

December 16, 2016 – 4:30 am

The 21st Century Cures Act is now law. New York wants to play in the biotech big leagues. The FDA under Trump will have license to approve drugs faster and could have a former top official back on…

[[Click headline to continue reading.]]

Organovo Discloses First Preclinical Data on Human Liver “Patch”

December 13, 2016 – 6:05 am

After taking the first steps toward the development of living human liver tissue “patches” for therapeutic use, San Diego-based Organovo (NASDAQ: ONVO) is laying out its pre-clinical data for the…

[[Click headline to continue reading.]]

San Diego Startup Raises $2.3M to Advance Enzymatic DNA Synthesis

December 12, 2016 – 5:30 am

Molecular Assemblies, a San Diego startup developing a new enzymatic method for synthesizing DNA, said today it has raised $2.3 million in a seed financing round. The funding will be used to hire…

[[Click headline to continue reading.]]

Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song”

December 9, 2016 – 11:41 am

When Eli Lilly (NYSE: LLY) reported the day before Thanksgiving, that its Alzheimer’s treatment solanezumab failed to significantly improve the condition of people with a mild form of the…

[[Click headline to continue reading.]]

Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More

December 9, 2016 – 4:30 am

What a week. The 21st Century Cures Act is now waiting President Obama’s promised signature after easy passage through Congress. President-elect Donald Trump re-stirred the drug-pricing pot…

[[Click headline to continue reading.]]

Craig Venter Used Own Posh Health Clinic To Diagnose His Cancer

December 8, 2016 – 5:17 am

Speaking at a conference in San Francisco Wednesday, geneticist Craig Venter revealed that he had just had surgery for prostate cancer three weeks ago. A health workup at his own high-end clinic,…

[[Click headline to continue reading.]]

Wake Up, Pharma—Trump Is Not Your Savior

December 7, 2016 – 10:01 pm

Since the election, leaders in biotechnology and pharmaceuticals are acting like they got away with robbery. The Nasdaq Biotechnology Index went up 9 percent overnight on November 8th. With Donald…

[[Click headline to continue reading.]]

Senate Approves 21st Century Cures Act, Sending Bill to Obama

December 7, 2016 – 2:32 pm

The U.S. Senate has voted overwhelmingly to approve the 21st Century Cures Act, a wide-ranging healthcare spending and reform bill that aims to infuse medical research with new funding and also speed…

[[Click headline to continue reading.]]